ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global High Purity 1,5-Pentanediamine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-27J17517
Home | Market Reports | Business & Industrial| Chemicals Industry
Global High Purity 1 5 Pentanediamine Market Research Report 2024
BUY CHAPTERS

Global High Purity 1,5-Pentanediamine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-27J17517
Report
October 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Daesang
Eppen
Cathay Biotech

High Purity 1,5-Pentanediamine Market

The global High Purity 1,5-Pentanediamine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
High-purity 1,5-pentanediamine refers to a high-purity 1,5-pentanediamine chemical obtained through special treatment or purification process. In the field of chemistry, high-purity chemicals usually refer to higher purity and lower impurity content, which can ensure more reliable results during experiments or production processes.
From a downstream perspective, Biopolyamide accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
High Purity 1,5-Pentanediamine leading manufacturers including Daesang, EPPEN, Cathay Biotech, etc., dominate supply; the top five capture approximately % of global revenue, with Daesang leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global High Purity 1,5-Pentanediamine market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of High Purity 1,5-Pentanediamine Market Report

Report Metric Details
Report Name High Purity 1,5-Pentanediamine Market
Segment by Type
  • ≥99.5%
  • ≥99.9%
  • Others
Segment by Application
  • Biopolyamide
  • Chemical Intermediates
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Daesang, EPPEN, Cathay Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the High Purity 1,5-Pentanediamine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the High Purity 1,5-Pentanediamine Market report?

Ans: The main players in the High Purity 1,5-Pentanediamine Market are Daesang, EPPEN, Cathay Biotech

What are the Application segmentation covered in the High Purity 1,5-Pentanediamine Market report?

Ans: The Applications covered in the High Purity 1,5-Pentanediamine Market report are Biopolyamide, Chemical Intermediates, Others

What are the Type segmentation covered in the High Purity 1,5-Pentanediamine Market report?

Ans: The Types covered in the High Purity 1,5-Pentanediamine Market report are ≥99.5%, ≥99.9%, Others

1 Study Coverage
1.1 Introduction to High Purity 1,5-Pentanediamine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global High Purity 1,5-Pentanediamine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ≥99.5%
1.2.3 ≥99.9%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global High Purity 1,5-Pentanediamine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biopolyamide
1.3.3 Chemical Intermediates
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global High Purity 1,5-Pentanediamine Revenue Estimates and Forecasts 2020-2031
2.2 Global High Purity 1,5-Pentanediamine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global High Purity 1,5-Pentanediamine Sales Estimates and Forecasts 2020-2031
2.4 Global High Purity 1,5-Pentanediamine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global High Purity 1,5-Pentanediamine Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global High Purity 1,5-Pentanediamine Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global High Purity 1,5-Pentanediamine Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 ≥99.5% Market Size by Manufacturers
4.5.2 ≥99.9% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global High Purity 1,5-Pentanediamine Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global High Purity 1,5-Pentanediamine Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global High Purity 1,5-Pentanediamine Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global High Purity 1,5-Pentanediamine Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global High Purity 1,5-Pentanediamine Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America High Purity 1,5-Pentanediamine Sales and Revenue by Type (2020-2031)
7.4 North America High Purity 1,5-Pentanediamine Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America High Purity 1,5-Pentanediamine Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe High Purity 1,5-Pentanediamine Sales and Revenue by Type (2020-2031)
8.4 Europe High Purity 1,5-Pentanediamine Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe High Purity 1,5-Pentanediamine Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific High Purity 1,5-Pentanediamine Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific High Purity 1,5-Pentanediamine Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific High Purity 1,5-Pentanediamine Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America High Purity 1,5-Pentanediamine Sales and Revenue by Type (2020-2031)
10.4 Central and South America High Purity 1,5-Pentanediamine Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America High Purity 1,5-Pentanediamine Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa High Purity 1,5-Pentanediamine Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa High Purity 1,5-Pentanediamine Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa High Purity 1,5-Pentanediamine Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Daesang
12.1.1 Daesang Corporation Information
12.1.2 Daesang Business Overview
12.1.3 Daesang High Purity 1,5-Pentanediamine Product Models, Descriptions and Specifications
12.1.4 Daesang High Purity 1,5-Pentanediamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Daesang High Purity 1,5-Pentanediamine Sales by Product in 2024
12.1.6 Daesang High Purity 1,5-Pentanediamine Sales by Application in 2024
12.1.7 Daesang High Purity 1,5-Pentanediamine Sales by Geographic Area in 2024
12.1.8 Daesang High Purity 1,5-Pentanediamine SWOT Analysis
12.1.9 Daesang Recent Developments
12.2 EPPEN
12.2.1 EPPEN Corporation Information
12.2.2 EPPEN Business Overview
12.2.3 EPPEN High Purity 1,5-Pentanediamine Product Models, Descriptions and Specifications
12.2.4 EPPEN High Purity 1,5-Pentanediamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 EPPEN High Purity 1,5-Pentanediamine Sales by Product in 2024
12.2.6 EPPEN High Purity 1,5-Pentanediamine Sales by Application in 2024
12.2.7 EPPEN High Purity 1,5-Pentanediamine Sales by Geographic Area in 2024
12.2.8 EPPEN High Purity 1,5-Pentanediamine SWOT Analysis
12.2.9 EPPEN Recent Developments
12.3 Cathay Biotech
12.3.1 Cathay Biotech Corporation Information
12.3.2 Cathay Biotech Business Overview
12.3.3 Cathay Biotech High Purity 1,5-Pentanediamine Product Models, Descriptions and Specifications
12.3.4 Cathay Biotech High Purity 1,5-Pentanediamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Cathay Biotech High Purity 1,5-Pentanediamine Sales by Product in 2024
12.3.6 Cathay Biotech High Purity 1,5-Pentanediamine Sales by Application in 2024
12.3.7 Cathay Biotech High Purity 1,5-Pentanediamine Sales by Geographic Area in 2024
12.3.8 Cathay Biotech High Purity 1,5-Pentanediamine SWOT Analysis
12.3.9 Cathay Biotech Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 High Purity 1,5-Pentanediamine Industry Chain
13.2 High Purity 1,5-Pentanediamine Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 High Purity 1,5-Pentanediamine Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 High Purity 1,5-Pentanediamine Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 High Purity 1,5-Pentanediamine Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global High Purity 1,5-Pentanediamine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Daesang
Eppen
Cathay Biotech
List of Tables
 Table 1. Global High Purity 1,5-Pentanediamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global High Purity 1,5-Pentanediamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global High Purity 1,5-Pentanediamine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global High Purity 1,5-Pentanediamine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global High Purity 1,5-Pentanediamine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global High Purity 1,5-Pentanediamine Sales by Region (2020-2025) & (Tons)
 Table 8. Global High Purity 1,5-Pentanediamine Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global High Purity 1,5-Pentanediamine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global High Purity 1,5-Pentanediamine Production by Region (2020-2025) & (Tons)
 Table 12. Global High Purity 1,5-Pentanediamine Production by Region (2026-2031) & (Tons)
 Table 13. Global High Purity 1,5-Pentanediamine Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global High Purity 1,5-Pentanediamine Sales Share by Manufacturers (2020-2025)
 Table 15. Global High Purity 1,5-Pentanediamine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global High Purity 1,5-Pentanediamine Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global High Purity 1,5-Pentanediamine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Purity 1,5-Pentanediamine as of 2024)
 Table 19. Global High Purity 1,5-Pentanediamine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global High Purity 1,5-Pentanediamine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers High Purity 1,5-Pentanediamine Manufacturing Base and Headquarters
 Table 22. Global High Purity 1,5-Pentanediamine Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global High Purity 1,5-Pentanediamine Sales by Type (2020-2025) & (Tons)
 Table 26. Global High Purity 1,5-Pentanediamine Sales by Type (2026-2031) & (Tons)
 Table 27. Global High Purity 1,5-Pentanediamine Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global High Purity 1,5-Pentanediamine Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global High Purity 1,5-Pentanediamine ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global High Purity 1,5-Pentanediamine Sales by Application (2020-2025) & (Tons)
 Table 32. Global High Purity 1,5-Pentanediamine Sales by Application (2026-2031) & (Tons)
 Table 33. High Purity 1,5-Pentanediamine High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global High Purity 1,5-Pentanediamine Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global High Purity 1,5-Pentanediamine Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global High Purity 1,5-Pentanediamine ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America High Purity 1,5-Pentanediamine Growth Accelerators and Market Barriers
 Table 40. North America High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America High Purity 1,5-Pentanediamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe High Purity 1,5-Pentanediamine Growth Accelerators and Market Barriers
 Table 43. Europe High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe High Purity 1,5-Pentanediamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific High Purity 1,5-Pentanediamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific High Purity 1,5-Pentanediamine Growth Accelerators and Market Barriers
 Table 48. Southeast Asia High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America High Purity 1,5-Pentanediamine Investment Opportunities and Key Challenges
 Table 50. Central and South America High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa High Purity 1,5-Pentanediamine Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa High Purity 1,5-Pentanediamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Daesang Corporation Information
 Table 54. Daesang Description and Major Businesses
 Table 55. Daesang Product Models, Descriptions and Specifications
 Table 56. Daesang Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Daesang Sales Value Proportion by Product in 2024
 Table 58. Daesang Sales Value Proportion by Application in 2024
 Table 59. Daesang Sales Value Proportion by Geographic Area in 2024
 Table 60. Daesang High Purity 1,5-Pentanediamine SWOT Analysis
 Table 61. Daesang Recent Developments
 Table 62. EPPEN Corporation Information
 Table 63. EPPEN Description and Major Businesses
 Table 64. EPPEN Product Models, Descriptions and Specifications
 Table 65. EPPEN Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. EPPEN Sales Value Proportion by Product in 2024
 Table 67. EPPEN Sales Value Proportion by Application in 2024
 Table 68. EPPEN Sales Value Proportion by Geographic Area in 2024
 Table 69. EPPEN High Purity 1,5-Pentanediamine SWOT Analysis
 Table 70. EPPEN Recent Developments
 Table 71. Cathay Biotech Corporation Information
 Table 72. Cathay Biotech Description and Major Businesses
 Table 73. Cathay Biotech Product Models, Descriptions and Specifications
 Table 74. Cathay Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Cathay Biotech Sales Value Proportion by Product in 2024
 Table 76. Cathay Biotech Sales Value Proportion by Application in 2024
 Table 77. Cathay Biotech Sales Value Proportion by Geographic Area in 2024
 Table 78. Cathay Biotech High Purity 1,5-Pentanediamine SWOT Analysis
 Table 79. Cathay Biotech Recent Developments
 Table 80. Key Raw Materials Distribution
 Table 81. Raw Materials Key Suppliers
 Table 82. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 83. Milestones in Production Technology Evolution
 Table 84. Distributors List
 Table 85. Market Trends and Market Evolution
 Table 86. Market Drivers and Opportunities
 Table 87. Market Challenges, Risks, and Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources


List of Figures
 Figure 1. High Purity 1,5-Pentanediamine Product Picture
 Figure 2. Global High Purity 1,5-Pentanediamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. ≥99.5% Product Picture
 Figure 4. ≥99.9% Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global High Purity 1,5-Pentanediamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Biopolyamide
 Figure 8. Chemical Intermediates
 Figure 9. Others
 Figure 10. High Purity 1,5-Pentanediamine Report Years Considered
 Figure 11. Global High Purity 1,5-Pentanediamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 13. Global High Purity 1,5-Pentanediamine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global High Purity 1,5-Pentanediamine Revenue Market Share by Region (2020-2031)
 Figure 15. Global High Purity 1,5-Pentanediamine Sales (2020-2031) & (Tons)
 Figure 16. Global High Purity 1,5-Pentanediamine Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global High Purity 1,5-Pentanediamine Sales Market Share by Region (2020-2031)
 Figure 18. Global High Purity 1,5-Pentanediamine Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global High Purity 1,5-Pentanediamine Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global High Purity 1,5-Pentanediamine Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. High Purity 1,5-Pentanediamine Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. High Purity 1,5-Pentanediamine Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. High Purity 1,5-Pentanediamine Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. High Purity 1,5-Pentanediamine Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers High Purity 1,5-Pentanediamine Sales Volume Market Share in 2024
 Figure 27. Global High Purity 1,5-Pentanediamine Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. ≥99.5% Revenue Market Share by Manufacturer in 2024
 Figure 30. ≥99.9% Revenue Market Share by Manufacturer in 2024
 Figure 31. Others Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 34. Global High Purity 1,5-Pentanediamine Sales Market Share by Type (2020-2031)
 Figure 35. Global High Purity 1,5-Pentanediamine Revenue Market Share by Type (2020-2031)
 Figure 36. Global High Purity 1,5-Pentanediamine Sales Market Share by Application (2020-2031)
 Figure 37. Global High Purity 1,5-Pentanediamine Revenue Market Share by Application (2020-2031)
 Figure 38. North America High Purity 1,5-Pentanediamine Sales YoY (2020-2031) & (Tons)
 Figure 39. North America High Purity 1,5-Pentanediamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. North America Top 5 Manufacturers High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) in 2024
 Figure 41. North America High Purity 1,5-Pentanediamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 42. North America High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 43. North America High Purity 1,5-Pentanediamine Sales Volume (Tons) by Application (2020-2031)
 Figure 44. North America High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. US High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 46. Canada High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 47. Mexico High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe High Purity 1,5-Pentanediamine Sales YoY (2020-2031) & (Tons)
 Figure 49. Europe High Purity 1,5-Pentanediamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Europe Top 5 Manufacturers High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) in 2024
 Figure 51. Europe High Purity 1,5-Pentanediamine Sales Volume (Tons) by Type (2020-2031)
 Figure 52. Europe High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Europe High Purity 1,5-Pentanediamine Sales Volume (Tons) by Application (2020-2031)
 Figure 54. Europe High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Germany High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 56. France High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 57. U.K. High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 58. Italy High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 59. Russia High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific High Purity 1,5-Pentanediamine Sales YoY (2020-2031) & (Tons)
 Figure 61. Asia-Pacific High Purity 1,5-Pentanediamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Top 8 Manufacturers High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) in 2024
 Figure 63. Asia-Pacific High Purity 1,5-Pentanediamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 64. Asia-Pacific High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 65. Asia-Pacific High Purity 1,5-Pentanediamine Sales Volume (Tons) by Application (2020-2031)
 Figure 66. Asia-Pacific High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Indonesia High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 68. Japan High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 69. South Korea High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 70. China Taiwan High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 71. India High Purity 1,5-Pentanediamine Revenue (2020-2031) & (US$ Million)
 Figure 72. Central and South America High Purity 1,5-Pentanediamine Sales YoY (2020-2031) & (Tons)
 Figure 73. Central and South America High Purity 1,5-Pentanediamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Central and South America Top 5 Manufacturers High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) in 2024
 Figure 75. Central and South America High Purity 1,5-Pentanediamine Sales Volume (Tons) by Type (2021-2031)
 Figure 76. Central and South America High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Central and South America High Purity 1,5-Pentanediamine Sales Volume (Tons) by Application (2020-2031)
 Figure 78. Central and South America High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. Brazil High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 80. Argentina High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 81. Middle East, and Africa High Purity 1,5-Pentanediamine Sales YoY (2020-2031) & (Tons)
 Figure 82. Middle East and Africa High Purity 1,5-Pentanediamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 83. Middle East and Africa Top 5 Manufacturers High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) in 2024
 Figure 84. Middle East and Africa High Purity 1,5-Pentanediamine Sales Volume (Tons) by Type (2021-2031)
 Figure 85. South America High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 86. Middle East and Africa High Purity 1,5-Pentanediamine Sales Volume (Tons) by Application (2020-2031)
 Figure 87. Middle East and Africa High Purity 1,5-Pentanediamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 88. GCC Countries High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 89. Turkey High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 90. Egypt High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 91. South Africa High Purity 1,5-Pentanediamine Revenue (2020-2025) & (US$ Million)
 Figure 92. High Purity 1,5-Pentanediamine Industry Chain Mapping
 Figure 93. Regional High Purity 1,5-Pentanediamine Manufacturing Base Distribution (%)
 Figure 94. High Purity 1,5-Pentanediamine Production Process
 Figure 95. Regional High Purity 1,5-Pentanediamine Production Cost Structure
 Figure 96. Channels of Distribution (Direct Vs Distribution)
 Figure 97. Bottom-up and Top-down Approaches for This Report
 Figure 98. Data Triangulation
 Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions